TR199902019T2 - Ikame edilmis tiazolidion' un hazirlanmasi için proses. - Google Patents

Ikame edilmis tiazolidion' un hazirlanmasi için proses.

Info

Publication number
TR199902019T2
TR199902019T2 TR1999/02019T TR9902019T TR199902019T2 TR 199902019 T2 TR199902019 T2 TR 199902019T2 TR 1999/02019 T TR1999/02019 T TR 1999/02019T TR 9902019 T TR9902019 T TR 9902019T TR 199902019 T2 TR199902019 T2 TR 199902019T2
Authority
TR
Turkey
Prior art keywords
formula
pharmaceutically acceptable
thiazolidion
rlanmas
edilmi
Prior art date
Application number
TR1999/02019T
Other languages
English (en)
Inventor
Gordon Giles Robert
John Lewis Norman
Moore Stephen
Ripley Pool Colin
Kirby Quick John
Urquhart Michael
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27268725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199902019(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9703310.4A external-priority patent/GB9703310D0/en
Priority claimed from GBGB9703338.5A external-priority patent/GB9703338D0/en
Priority claimed from GBGB9703334.4A external-priority patent/GB9703334D0/en
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR199902019T2 publication Critical patent/TR199902019T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

J' nin O veya S'yi temsil ettigi; T' nin ikame edilmis ya da ikame edilmemis bir aril grubunu temsil ettigi ve T1'in O ya da S oldugu bir formül (I) bilesigi ya da bunun totomerik bir formunu ya da farmasötik olarak kabul edilebilir bir tuzunu veya farmasötik olarak kabul edilebilir bir solvatini hazirlamak için; T ve T1'in formül (I) ' deki gibi oldugu bir formül (II) bilesiginin ya da bunun totomerik bir formunun, ya da bir tuz veya hidratinin karmasik bir hidrid redüksiyon maddesi veya karmasik bir hidrid redüksiyon maddesinin kaynagi ile indirgenmesini; ve ardindan da istenirse, formül (I) bilesiginin ya da bunun totomerik bir formunun farmasötik olarak kabul edilebilir bir tuzunun veya farmasötik olarak kabul edilebilir bir solventinin hazirlanmasini kapsayan bir proses. FORMÜL (I) FORMÜL (II)
TR1999/02019T 1997-02-18 1998-02-13 Ikame edilmis tiazolidion' un hazirlanmasi için proses. TR199902019T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9703310.4A GB9703310D0 (en) 1997-02-18 1997-02-18 Novel process
GBGB9703338.5A GB9703338D0 (en) 1997-02-18 1997-02-18 Novel process
GBGB9703334.4A GB9703334D0 (en) 1997-02-18 1997-02-18 Novel compounds

Publications (1)

Publication Number Publication Date
TR199902019T2 true TR199902019T2 (tr) 1999-12-21

Family

ID=27268725

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02019T TR199902019T2 (tr) 1997-02-18 1998-02-13 Ikame edilmis tiazolidion' un hazirlanmasi için proses.

Country Status (29)

Country Link
EP (2) EP0970063A1 (tr)
JP (2) JP2001514619A (tr)
KR (1) KR20000071138A (tr)
CN (1) CN1252065A (tr)
AP (1) AP1359A (tr)
AR (1) AR011447A1 (tr)
AU (1) AU6622398A (tr)
BG (1) BG64311B1 (tr)
BR (1) BR9807395A (tr)
CA (1) CA2281695C (tr)
CZ (1) CZ296272B6 (tr)
DZ (1) DZ2430A1 (tr)
EA (1) EA199900754A1 (tr)
HU (1) HUP0001459A3 (tr)
ID (1) ID22222A (tr)
IL (1) IL131392A (tr)
IN (1) IN188379B (tr)
MA (1) MA24475A1 (tr)
MY (1) MY129475A (tr)
NO (2) NO313290B1 (tr)
NZ (1) NZ337179A (tr)
OA (1) OA11148A (tr)
PE (1) PE71899A1 (tr)
PL (1) PL195482B1 (tr)
SK (2) SK285979B6 (tr)
TR (1) TR199902019T2 (tr)
TW (1) TWI222446B (tr)
UY (1) UY24886A1 (tr)
WO (1) WO1998037073A1 (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723295D0 (en) 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
US7091359B2 (en) 1997-11-04 2006-08-15 Smithkline Beecham Plc Process for the preparation of thiazolidinedione derivatives
PL351684A1 (en) * 1999-04-23 2003-06-02 Smithkline Beecham Plc Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt
FR2820742B1 (fr) * 2001-02-14 2005-03-11 Ppg Sipsy Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine
FR2820741A1 (fr) * 2001-02-14 2002-08-16 Ppg Sipsy Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine
US7767701B2 (en) 2002-11-22 2010-08-03 Glaxosmithkline Llc Chemical compounds
AR047541A1 (es) * 2004-02-13 2006-01-25 Sandoz Ag Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
EP1745043A1 (en) * 2004-05-12 2007-01-24 Medichem S.A. Process for the preparation of rosiglitazone
CZ297266B6 (cs) * 2004-09-10 2006-10-11 Zentiva, A. S. Zpusob prípravy rosiglitazonu
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
JPH0377875A (ja) * 1989-08-18 1991-04-03 Kaken Pharmaceut Co Ltd チアゾリジン‐２，４‐ジオン誘導体およびその製造法
EP0839812A1 (en) * 1990-04-27 1998-05-06 Sankyo Company Limited Preparation of benzylthiazolidine derivatives
AU3231093A (en) * 1991-12-20 1993-07-28 Upjohn Company, The A reduction method for substituted 5-methylene-thiazolidinediones
JPH08157473A (ja) * 1994-10-06 1996-06-18 Nissan Chem Ind Ltd ピラゾール系チアゾリジン類
JPH08217717A (ja) * 1995-02-10 1996-08-27 Sumitomo Chem Co Ltd 環状ケトン系化合物、その製造法およびそれを有効成分とするゴキブリ誘引剤
KR100399798B1 (ko) * 1995-05-31 2004-05-31 스미또모 세이야꾸 가부시키가이샤 신규나프티리딘유도체

Also Published As

Publication number Publication date
TWI222446B (en) 2004-10-21
WO1998037073A1 (en) 1998-08-27
JP2009149616A (ja) 2009-07-09
NO993949L (no) 1999-09-07
CZ296272B6 (cs) 2006-02-15
EA199900754A1 (ru) 2000-04-24
IN188379B (tr) 2002-09-14
BG103735A (en) 2000-06-30
BG64311B1 (bg) 2004-09-30
IL131392A0 (en) 2001-01-28
PL195482B1 (pl) 2007-09-28
AP9901626A0 (en) 1999-09-30
JP2001514619A (ja) 2001-09-11
EP0970063A1 (en) 2000-01-12
CA2281695C (en) 2006-12-12
OA11148A (en) 2003-04-16
HUP0001459A3 (en) 2002-11-28
MY129475A (en) 2007-04-30
DZ2430A1 (fr) 2003-01-11
NZ337179A (en) 2001-07-27
SK112099A3 (en) 2000-05-16
ID22222A (id) 1999-09-16
AP1359A (en) 2004-12-02
NO313290B1 (no) 2002-09-09
HUP0001459A2 (hu) 2000-10-28
KR20000071138A (ko) 2000-11-25
PE71899A1 (es) 1999-09-15
CA2281695A1 (en) 1998-08-27
PL335163A1 (en) 2000-04-10
AR011447A1 (es) 2000-08-16
CN1252065A (zh) 2000-05-03
BR9807395A (pt) 2000-03-14
UY24886A1 (es) 2001-08-27
CZ292499A3 (cs) 2000-02-16
AU6622398A (en) 1998-09-09
NO20023937D0 (no) 2002-08-19
NO20023937L (no) 1999-09-07
EP1770092A1 (en) 2007-04-04
MA24475A1 (fr) 1998-10-01
SK287512B6 (sk) 2010-12-07
SK285979B6 (sk) 2007-12-06
IL131392A (en) 2005-07-25
NO993949D0 (no) 1999-08-17

Similar Documents

Publication Publication Date Title
PL327169A1 (en) Naphtyl-substituted derivatives of benzimidazole as anticoagulants
CA2173150A1 (en) Novel peptide derivatives
IL129068A0 (en) Sulfinic acid derivatives and their preparation and use
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
CA2030519A1 (en) Acryloyl substituted pyrrole derivatives
AU537028B2 (en) Imidazole derivatives
CA2297011A1 (en) Sulfonamide derivatives as therapeutic or prophylactic agent for glomerulopathy
TR199902019T2 (tr) Ikame edilmis tiazolidion' un hazirlanmasi için proses.
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
CA2286511A1 (en) Novel macrolide derivatives
CA2260060A1 (en) Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
TR199902213T2 (tr) Pirazol türevleri hazirlanmasi için bir proses.
CA2385200A1 (en) 4-hydroxybiphenyl hydrazide derivatives
CA2311344A1 (en) 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
DE69330601T2 (de) Serotoninergische ergolin derivate
CA2204204A1 (en) Carbohydrate derivatives
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
AU1971688A (en) Benzimidazole derivatives, their preparation and their application in therapeutics
CA2088702A1 (en) Aminobenzoic acid derivatives
WO2001017955A3 (en) Hydroxyacetamidobenzenesulphonamide derivatives
AP9801235A0 (en) Erythromycin derivatives.
CA2326716A1 (en) Triazolopurine derivative, pharmaceutical composition containing the derivative, adenosine a3 receptor ligand, and remedy for asthma
CA2128202A1 (en) Alkyl Derivatives of Trazodone with CNS Activity
CA2309485A1 (en) New 4-arylpiperidine derivatives for the treatment of pruritus
CA2245484A1 (en) Novel urea derivatives